Techulon Inc - Company Review
Techulon Inc - Company ReviewSummary
Techulon Inc (Techulon) is an early-stage translational company that focuses on the development of nucleic acid therapeutics. It uses Peptide-Peptide Nucleic Acid (PPNA) technology which yields antisense agents for different bacteria including S aureus, aeruginosa, and A. baumannii. The company is developing therapies for its lead candidate methicillin-resistant staphylococcus aureus (MRSA), gram negative bacteria and other bacterial infections. Its approach is enabled by genomic techniques that have a point of application toward neutralization of bacterial strains. Techulon also develops drugs for treatment of multi-drug resistant (MDR) bacteria and wound healing. It works in collaboration with Virginia Tech. Techulon is headquartered in Blacksburg, Virginia, the US.
This comprehensive company report of Techulon Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.